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Abstract
Previous work with Sprague–Dawley (SD) rats indicated that subjecting these rats to multiple
episodes of ethanol diet could provoke anxiety-like responses. Because alcohol-preferring P rats have
been reported to have neurochemical alterations in many systems shown to modulate anxiety-like
responses, P rats were compared to SD rats. Rats were subjected to one or three cycles of 5 days’
exposure to 4.5% or 7% ethanol diet to assess anxiety-like behavior. The social interaction test was
conducted 5 h after ethanol was removed. Other groups of P and SD rats were injected with flumazenil
(5 mg/kg), a benzodiazepine (BZD) receptor antagonist, CP-154,526 (10 mg/kg), CRF1 receptor
antagonist, SB243,213, a 5-HT2C receptor inverse agonist, or vehicle during the 1st and 2nd
withdrawals but not the third. After a single 5-day cycle of ethanol exposure, SD rats did not exhibit
a change in social interaction, but P rats exhibited a decrease after exposure to the 7% ethanol. Both
strains of rats exhibited anxiety-like behavior following three cycles of exposure to ethanol and the
concentration of ethanol in the diet did not influence the response. It was confirmed that flumazenil,
CP-154,523, and SB243,213 had prophylactic effects on anxiety-like behavior in the SD rats. Neither
flumazenil nor SB243,213 was as effective in the P rats, while the CRF1 receptor antagonist
completely counteracted the reduced social interaction in repeatedly withdrawn P rats. A small study
showed that buspirone, a 5-HT1A agonist, also had prophylactic effects in P rats. These findings show
that alcohol-preferring P rats exhibit anxiety-like behavior more readily following exposure to
ethanol-containing diets and that this behavior is counteracted more readily by pretreatment with a
CRF1 receptor antagonist than with BZD or 5-HT2C receptor antagonists.
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1. Introduction
Previous work from our laboratory showed that Sprague–Dawley (SD) rats will exhibit anxiety-
like behavior (reductions in social interaction behavior) when exposed to repeated cycles of
ethanol-containing diet (Overstreet et al., 2002), providing further evidence for a sensitization
process in animals and humans chronically exposed to ethanol (e.g., Holter et al., 1998;
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Malcolm et al., 2000; McCown and Breese, 1990). Because of the nature of our repeated cycle
protocol, with three cycles of 5 days’ exposure to ethanol being separated by two 2-day periods
of withdrawal, it was possible to examine the prophylactic effects of drugs known or
hypothesized to modulate anxiety. For example, flumazenil, an benzodiazepine (BZD) receptor
antagonist, acutely reduced the anxiety-like behavior of ethanol-withdrawn rats (File et al.,
1989; Moy et al., 1997, 2000; Knapp et al., 2004) and had the prophylactic effect of reducing
the anxiety-like behavior after the 3rd withdrawal when given only during the 1st and 2nd
withdrawals (Knapp et al., 2005). Serotonin (5-HT) and corticotropin releasing factor (CRF)
also appear to be involved because a 5-HT2C receptor antagonist, a 5-HT1A receptor agonist,
and a CRF1 receptor antagonist also reduced the anxiety-like behavior in rats subjected to
repeated withdrawals from ethanol (Overstreet et al., 2003, 2004a). The counteraction of
anxiety in alcohol-withdrawn rats by these drugs suggests that they might play a therapeutic
role in the management of anxiety in alcoholics (See Breese et al., 2004b; Potokar et al.,
1997; Seymour et al., 2003).
The alcohol-preferring P rat was developed by selectively breeding from Wistar rats that drank
high volumes of ethanol solution voluntarily (e.g., Li et al., 1993; Murphy et al., 2002). An
extensive amount of behavioral and physiological data have accumulated on P rats (Murphy
et al., 2002). Of particular interest to the present project is the realization that the P rat has a
number of neurotransmitter abnormalities found to modulate ethanol withdrawal-induced
anxiety, including GABA (Hwang et al., 1990), BZD (Thielen et al., 1993,1997, 1998), 5-HT
(McBride et al., 1997; Murphy et al., 1987; Pandey et al., 1996; Zhou et al., 1991), and CRF
(Ehlers et al., 1992; Hwang et al., 2001) mechanisms. It is, possible therefore, that these
alterations could affect the response of the P rat to chronic and repeated exposures to ethanol
and/or to the effects of these agents.
The purpose of the present investigation was threefold: (1) to assess whether the P rat would
react to ethanol diet manipulations in a manner similar to the SD rat; (2) to determine whether
compounds known to counteract anxiety-like behavior induced by repeated ethanol withdrawal
in SD rats would be equally effective in alcohol-preferring P rats; (3) to evaluate whether known
neurochemical alterations in the P rat might account for the differential responses.
2. Materials and methods
2.1. Animals
Male Sprague–Dawley (SD) rats (Charles-River, Raleigh) were purchased at 40 days of age
(160–180 g). The alcohol-preferring inbred P rats were selected from breeding colonies
maintained at the UNC Bowles Center for Alcohol Studies at similar weights and ages. After
5 days to adapt to new conditions (22 °C, 50% humidity, 12:12 light–dark cycle with lights on
between 0900 and 2100), they were placed on a nutritionally complete diet used previously in
our laboratory (e.g., Frye et al., 1983; Knapp et al., 1998; Moy et al., 2000; Overstreet et al.,
2002). Intakes of the liquid diet were recorded daily and body weights were measured weekly.
These experiments were conducted in accordance with the Guide for the Care and Use of
Laboratory Animals (NRC, 1996) and were approved by the UNC Institutional Animal Care
and Use Committee.
2.2. Liquid diet
Briefly, the diet was a lactalbumin/dextrose-based, nutritionally complete diet (with
concentrations of vitamins, minerals and other nutrients derived from ICN Research Diets).
Dextrose calories in the control diet (CD) were equated with ethanol calories in the ethanol
diet (ED, 4.5 or 7%, w/v).
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A modified pair-feeding design was used in all of the diet studies. The rats maintained on the
CD were given a volume of diet equivalent to the average volume consumed the previous day
by the rats maintained on the ED. The rats were weighed at weekly intervals and volumes of
diet were adjusted to insure that the groups had similar body weights. Behavioral assessments
were conducted after 5 or 15 days of exposure to the ED between 5 and 6 h after the removal
of the ethanol. This time point was selected on the basis of previous observations of anxiety-
like behavior in our laboratory (e.g., Knapp et al., 1998; Moy et al., 1997, 2000; Overstreet et
al., 2002).
2.3. Social interaction test
The social interaction test involves placing a pair of animals in an arena and measuring the
amount of time engaged in such behaviors as grooming, sniffing, crawling over or under, and
boxing; locomotor activity is simultaneously recorded and provides a measure that is
independent of social interaction (File and Seth, 2003; Overstreet et al., 2002, 2003). Social
interaction has been repeatedly validated as an index of anxiety-related behavior (See File and
Seth, 2003). Of particular relevance to the present study is the observation that social interaction
behavior is decreased following withdrawal from drugs of abuse, including ethanol (Andrews
et al., 1997; Costall et al., 1990; File et al., 1989; Irvine et al., 2001; Kampov-Polevoy et al.,
2000; Overstreet et al., 2002). This task has been used to monitor changes in anxiety-like
behavior in rats subjected to repeated withdrawals from ethanol as well as injected with drugs
to modify the consequences of ethanol withdrawal (Breese et al., 2004a; Overstreet et al.,
2002, 2003, 2004a; Knapp et al., 2005).
A modification of the standard social interaction test was used to reduce the number of animals
needed for experiments. Pairs of rats with the same treatment and similar body weights were
placed in the arena and the social interactions initiated by each member of the pair were
recorded, thereby requiring fewer rats. Previous studies have shown that the time spent in social
interaction of one member of the pair does not influence the social interaction of the other
member (Breese et al., 2004a; Overstreet et al., 2002, 2003, 2004a).
Experienced observers who were blind to the experimental condition carried out the social
interaction test in a square open field (60 cm by 60 cm, with 16 squares marked out on the
floor). The rats were unfamiliar with the open field and the lighting conditions were low (30
lx) in order to generate an intermediate level of anxiety-related behavior. Rat pairs were
matched on the basis of ethanol intakes, body weights, and treatment conditions and placed
simultaneously in the open field. During the 5-min session, line crosses (by two forepaws) and
time spent in social interaction (grooming, sniffing, following, crawling over/under) were
scored individually for each rat (Kampov-Polevoy et al., 2000; Overstreet et al., 2002).
2.4. Procedure
Several distinct experiments were performed, as described in Table 1. The concentration of
ethanol in the diet was 7% for some experiments to allow comparison with our previous studies
(e.g., Knapp et al., 2004;Overstreet et al., 2002). However, 4.5% ethanol was used in other
studies because of the realization that locomotor activity was not affected (Overstreet et al.,
2002), thereby providing a clearer interpretation of the manipulations on social interaction.
2.4.1. Repeated exposures to 7% ethanol—Rats were exposed to CD throughout the
study or to ED (7%, w/v) for either 5 or 15 days. Those given 15 days of ED were given 3
cycles of 5 days’ exposure with two withdrawal days between each cycle, during which time
they received CD. Between 5 and 6 h after removal of the ethanol, pairs of rats were placed in
the open field arena for the recording of social interaction behavior and line crosses over 5
min. During this withdrawal period, the rats had free access to CD. There were 8–10 rats from
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each strain in each of three treatment groups: control diet, one 5-day cycle of 7% ethanol diet,
three 5-day cycles of 7% ethanol diet.
2.4.2. Repeated exposures to 4.5% ethanol—Rats were exposed to CD throughout the
study or to ED (4.5%, w/v) for either 5 or 15 days. Those given 15 days of ED were given 3
cycles of 5 days’ exposure with two withdrawal days between each cycle, during which time
they received CD. Between 5 and 6 h after removal of the ethanol, pairs of rats were placed in
the open field arena for the recording of social interaction behavior and line crossings over 5
min. During this withdrawal period, the rats had free access to CD. There were 8–10 rats from
each strain in each of three treatment groups: control diet, one 5-day cycle of 4.5% ethanol
diet, three 5-day cycles of 4.5% ethanol diet.
2.4.3. Prophylactic treatment with flumazenil—Rats were exposed to CD throughout
or to 15 days of ED (7%, w/v) in three cycles of 5 days. During the 1st and 2nd withdrawals,
the rats were injected i.p. with either 5 mg/kg flumazenil or carboxymethylcellulose (CMC,
0.5%) vehicle 4 h after the ethanol was removed. Thus, there were three treatment groups:
control diet (CD); ethanol diet given vehicle (EDV), and ethanol diet given flumazenil (EDF).
There were 8–10 rats per group.
2.4.4. Prophylactic treatment with SB243,213—The SD and P rats were exposed to 3
cycles of 4.5% ethanol diet or control diet. At about 4 h into the 1st and 2nd withdrawals, the
ethanol-exposed rats were injected with CMC vehicle or SB243,213 (3 mg/kg). The social
interaction test was carried out 5 h after the final ethanol exposure was withdrawn. Thus, there
were three treatment groups for each strain: control diet (CD), ethanol diet given vehicle (EDV),
and ethanol diet given SB243,213 (EDSB). There were 6–8 rats per group.
2.4.5. Prophylactic treatment with CP-154,526—This study took advantage of the fact
that rats subjected to 4.5% ED exhibited a reduction in social interaction during the third
withdrawal (Overstreet et al., 2002; Experiment 2). Rats were maintained on control diet or 15
days of 4.5% ED, in three 5-day cycles. The rats exposed to ED were injected with either CMC
vehicle or CP-154,526 (10 mg/kg, i.p.), a CRF1 receptor antagonist, 4 h after the ethanol was
removed during the 1st and 2nd cycles. There were 8 rats in the CD group and 5 in each of the
ED groups. This study was conducted in P rats only. A similar study has recently been published
in the SD rats (Overstreet et al., 2004a).
A second study took advantage of the observation that exposure to restraint stress can potentiate
the effects of ethanol withdrawal (Breese et al., 2004a). The P rats were either exposed to CD
throughout or to one cycle of 5 days of 4.5% ED. The rats exposed to ED were either unstressed,
stressed after being given vehicle, or stressed after being given CP-154,526 (10 mg/kg). The
1-h restraint sessions occurred 30 min after the injections and 1 and 6 days before being exposed
to ED. The social interaction test was carried out between 5 and 6 h after the ethanol was
removed. There were 8 rats per treatment group: control diet (CD), ethanol diet (ED), ethanol
diet stressed and given Vehicle (EDSTV), and ethanol diet stressed and given CP-154,526
(EDSTC).
2.5. Statistical analysis
The time spent in social interaction was summarized as mean sec±S.E.M., while activity was
summarized as mean number of line crosses±S.E.M. The data were analyzed by two-way or
one-way analyses of variance (ANOVA), depending on the characteristics of the data set.
Follow-up analyses were carried out with Tukey’s protected t tests.
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3.1. Exposure to 7% ethanol
The data for time spent in social interaction in P and SD rats exposed to 7% ED are illustrated
in Fig. 1, upper panel. The groups exposed to CD are similar, suggesting that P rats are not
innately more anxious in the social interaction test. The P rats exhibited an anxiety-like
behavior after exposure to a single cycle of 5 days’ exposure, but the SD rats did not (Fig. 1).
However, both groups exhibited much less time spent in social interaction after 3 cycles of 5
days’ exposure to ED (Fig. 1). Analysis with two-way ANOVA confirmed these impressions.
There were significant treatment (F[2,42] = 36.32, p < 0.0001), strain (F[1,42] = 5.53 p < 0.01),
and interaction (F[2,42] = 13.56, p < 0.0001) effects. Thus, P rats are more sensitive to the
anxiety-like behavior induced by ethanol withdrawal. For line crosses, both P and SD rats
exhibited reductions after either one or three cycles of exposure (Fig. 1, lower panel). There
was a significant treatment effect (F[2,42] = 16.54, p < 0.001) but no significant strain or
interaction effects (p > 0.1).
3.2. Exposure to 4.5% ethanol
As illustrated in the upper panel of Fig. 2, the pattern for social interaction behavior in P and
SD rats after exposure to 4.5% ED was different from that after exposure to 7% ED (Fig. 1).
Now, neither strain was affected by exposure to 5 days of ED, but both exhibited anxiety-like
behavior following exposure to 3 cycles of ED. Thus, the 2-way ANOVA showed that there
was a significant treatment effect (F[2,42] = 25.32, p < 0.0001) but no significant strain (F
[1,42] = 1.25, NS) or interaction (F[2,42] = 0.79, NS) effects. Exposure to 4.5% ED did not
significantly affect locomotor activity in either strain (all p > 0.1; Fig. 2, lower panel).
Alcohol intakes during the 1st and last cycles of exposure to 4.5% or 7% ED are illustrated in
Fig. 3. Both groups had very high ethanol intakes. However, on 3 of the 4 comparisons, the P
rat drank significantly more ethanol than the SD rat. It should be stressed that the ethanol is in
the liquid diet and the rat cannot avoid drinking it. Nevertheless, it appears that the P rat drinks
more ethanol under these forced conditions than does the SD rat. Blood ethanol levels were
not recorded in this study, but earlier experiments in SD rats showed that the levels in rats
exposed to 7% ED were 100–125 mg% during the first two cycles and about 200 mg% at the
end of the third cycle (Overstreet et al., 2002).
3.3. Treatment with flumazenil
Rats of both strains that were exposed to 3 cycles of 5 days 7% ED exhibited large reductions
in time spent in social interaction (Fig. 4, upper panel), as noted in Fig. 1. As previously reported
(Knapp et al., 2005), flumazenil pretreatment during the 1st and 2nd withdrawals significantly
counteracted this anxiety-like behavior in the SD rats. However, in the P rats, flumazenil
treatment was only partially effective. Consequently, the 2-way ANOVA revealed significant
treatment (F[2,42] = 41.84, p < 0.0001), strain (F[1,42] = 24.67, p < 0.001), and interaction
(F[2,42] = 3.24, p < 0.05) effects.
As illustrated in the lower panel of Fig. 4, the pattern of the prophylactic effects of flumazenil
on locomotor activity was different from that on social interaction. Both strains exhibited
reduced line crosses after exposure to 3 cycles of 7% ED and both showed partial recovery
when pretreated with flumazenil. Therefore, the two-way ANOVA revealed only a significant
treatment effect (F[2,42] = 30.87, p < 0.0001). The strain (F[1,42] = 0.62, NS) and interaction
(F[2,42] = 0.15, NS) effects were not significant.
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3.4. Treatment with SB243,213
The effects of SB243,213 on social interaction behavior and line crosses in repeatedly
withdrawn P and SD rats were fairly straight forward (Fig. 5). By far the most noteworthy
finding was the significant treatment effect (F[2,34] = 58.48, p < 0.0001 for social interaction;
F[2,34] = 24.11, p < 0.0001 for line crosses). There were also significant strain effects (F[2,34]
= 9.16, p < 0.01 for social interaction; F[2,34] = 4.38, p < 0.05 for line crosses) but there were
no significant interaction effects for either social interaction (F[2,34] = 2.80, p = 0.08) or line
crosses (F[2,34] = 0.32, NS). The simple conclusion is that SB243,213 was partially effective
in counteracting the reduced social interaction in the SD rats but not in the P rats (Fig. 5, upper
panel). The reduced activity was unaffected by treatment with SB243,213 (Fig. 5, lower panel).
3.5. Treatment with CP-154,526
As was previously found in SD rats (Overstreet et al., 2004a), pretreatment with the CRF1
receptor antagonist CP154,526 counteracted the anxiety-like behavior in P rats induced by 3
cycles of exposure to 4.5 ED, as illustrated in the upper panel of Fig. 6. A one-way ANOVA
confirmed the significant group differences (F[2,21] = 36.73, p < 0.001) and follow-up Tukey’s
tests indicated that the group pretreated with CP154,526 engaged in significantly more social
interaction than the group given vehicle. There were no differences (F[2,21] = 2.63, p > 0.05)
in line crossings (Fig. 6, lower panel).
Fig. 7 shows that, as with SD rats, prior exposure to restraint stress in P rats results in anxiety-
like behavior following exposure to a single 5-day cycle of 4.5% ED (Breese et al., 2004a).
Pretreatment with CP154,526 30 min prior to each of these stresses prevented the anxiety-like
behavior (Fig. 7, upper panel). Analyses with one-way ANOVA (F[3,28] = 42.46, p < 0.0001)
and subsequent Tukey’s tests indicated that the stressed group exhibited less social interaction
than the rats exposed to CD or one cycle of ED and that the rats pretreated with CP154,526
exhibited a significantly higher time spent in social interaction than the group given vehicle.
Once again, there were no significant effects on line crosses (F[3,28] = 2.47, p > 0.05; Fig. 7,
lower panel).
4. Discussion
The alcohol-preferring P rats exhibit similar anxiety-related behavior in the social interaction
test to the SD rats following one or three cycles of exposure to 4.5% ED (Fig. 2) or three cycles
of exposure to 7% ED (Fig. 1). They differed only in their response to a single cycle of exposure
to 7% ED (Fig. 1). This pattern of results suggests that the P rat is more sensitive to the
withdrawal effects of ethanol.
A fairly straightforward explanation for this difference could be differences in alcohol intake,
with the P rats generally having higher alcohol intakes than the SD rats (Fig. 3). However, a
closer examination of our data indicates that this explanation is not adequate. The exposure
condition which differentiated the behavior of the P and SD rats was a single cycle of 5 days
exposure to 7% ED, but the strains did not differ in alcohol intake in this condition (Fig. 3).
On the other hand, the P and SD rats exhibited differences in alcohol intake after the other
exposure conditions, but they did not exhibit differences in social interaction behavior.
Flumazenil was less effective in counteracting ethanol withdrawal-induced anxiety in the P rat
(Fig. 4). Differences in BZD receptor function in the P rat (Thielen et al., 1993,1997,1998)
could account for this reduced effectiveness of flumazenil. Compared to nonalcohol-preferring
(NP) rats, the P rats have elevated BZD receptors (Thielen et al., 1997) and exhibit a greater
response to a BZD agonist (Thielen et al., 1993). Such enhanced BZD function in the P rats
would make it more difficult for flumazenil to block these BZD receptors and, consequently,
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less effective in counteracting the anxiety-like behavior. However, there is a caveat to this
apparently straightforward explanation. There are no data indicating that the BZD receptor
function in SD rats is similar to the NP rats and, therefore, less than that of the P rats. The
changes in GABA (A) receptor function observed in the P rat after isolation (Thielen et al.,
1993) would not appear to be a contributing factor to the results observed here because
comparable changes have been reported in Sprague–Dawley and other outbred rats (Dong et
al., 1999;Insel, 1989;Ojima et al., 1997;Serra et al., 2000).
One of the key findings in the P rats is a reduction in 5-HT content in many limbic regions
(Murphy et al., 1987). An interbreeding study has confirmed that low 5-HT content and high
alcohol intake are associated in the F2 crosses (McBride et al., 1995). Of particular relevance
to this study, however, is a report that the 5-HT2C receptors are elevated in the amygdala of
the P rats compared to the NP rats (Pandey et al., 1996). We have recently reported that alcohol
withdrawal induced anxiety-like behavior can be counteracted by injections of the 5-HT2C
receptor inverse agonist, SB-243,213, directly into the amygdala (Overstreet et al., 2004b). If
alcohol-preferring P rats have elevated 5-HT2C receptors relative to SD rats, then one might
expect them to be resistant to the prophylactic effects of the compound, as was found to be the
case (Fig. 5).
The CRF1 receptor antagonist, CP-154,526, was very effective in counteracting both multiple
withdrawal- and stress-induced increases in anxiety-like behavior (Figs. 6 and 7). It appears,
therefore, that the compound is as effective in P rats as it is in SD rats (Overstreet et al.,
2004a), unlike flumazenil and SB-243,213. Although there are reports of lower CRF levels in
the P rat relative to the NP rat (Ehlers et al., 1992;Hwang et al., 2001), it is not clear what
impact these differences might have on CRF receptors and there appears to be no data on this
measure. If the receptors had increased in response to the low levels of CRF, it would have
been predicted that the CRF1 receptor antagonist would not be as effective in the P rats. Clearly,
that is not the case, and it is likely that the CRF receptors in the P rats are functioning normally.
These findings support the view that the neurochemical background of the alcohol-preferring
P rats does influence its response to drugs that have been reported to have a prophylactic effect
in the repeated ethanol withdrawal paradigm. Importantly, the anxiety-like behavior of the P
rats was ameliorated very well by a CRF1 receptor antagonist, a finding that provides further
support for the potential use of this class of compounds as anxiolytic agents (Heinrichs et al.,
1997; Kehne and De Lombaert, 2002; Seymour et al., 2003).
These strain-dependent prophylactic effects also have important clinical implications. Because
each of these agents has both acute and prophylactic anxiolytic effects, they might prove useful
in treating alcoholics during the detoxification phase and thereby lessen the impact of anxiety
on relapse (e.g., Sloan et al., 2003). To the extent that alcoholics have neurochemical
abnormalities similar to those shown by the P rat, they may be resistant to the anxiolytic effects
of certain classes of drugs (See Breese et al., 2004b). The fact that the CRF1 receptor antagonist
CP-154,526 counteracted the anxiety-like behavior of both P (Figs. 6 and 7) and SD rats
(Breese et al., 2004a; Overstreet et al., 2004a) supports the view that these drugs deserve further
attention as potential therapeutic agents for alcoholism.
Another drug that has been successful in reducing anxiety-like behavior in SD rats repeatedly
exposed and withdrawn from ethanol is buspirone, a partial 5-HT1A agonist (Overstreet et al.,
2003). To determine whether a similar prophylactic effect could be seen in P rats, 4 animals
were exposed to 3 cycles of 5 days’ exposure to 4.5% alcohol diet and treated with 0.6 mg/kg
buspirone at 4 h into the first and second withdrawals. The time spent in social interaction (18.8
± 2.4 s) was not significantly different from that of a group of 8 rats maintained on control diet
(25.3 ± 1.9; t = 2.11, p > 0.05). Thus, buspirone appears to have similar prophylactic effects
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in P and SD rats. These effects are consistent with the early reports of the effectiveness of
buspirone in managing alcohol detoxification (Dougherty and Gates, 1990; Tollefson et al.,
1992), even though later studies indicated that buspirone was relatively ineffective in
preventing relapse in alcoholics (e.g., Malec et al., 1996). Thus, buspirone and the other drugs
used in this study may play a role in treatment of alcoholics, but not as traditional anti-relapse
agents (see Breese et al., 2004b). Indeed, they might be most effective if given in conjunction
with naltrexone or acamprosate.
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Repeated exposures to 7% ethanol diet in P and SD rats. Rats were exposed to control liquid
diet continuously or 7% ethanol diet (ED) in three cycles of 5 days, with 2 days of withdrawal
after each cycle. The social interaction test was carried out after the 1st or 3rd cycles. Upper
panel: data represent the mean sec±S.E.M. for 8–10 rats; lower panel: data represent the mean
line crosses±S.E.M. Groups with different letters are significantly different, p < 0.01, according
to 2-way ANOVA and Tukey’s protected t tests.
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Repeated exposures to 4.5% ethanol diet in P and SD rats. Rats were exposed to control liquid
diet continuously or 4.5% ethanol diet (ED) in three cycles of 5 days, with 2 days of withdrawal
after each cycle. The social interaction test was carried out after the 1st or 3rd cycles. Upper
panel: data represent the mean sec±S.E.M. for 8–10 rats. Lower panel: data represent the mean
line crosses±S.E.M. Groups with different letters are significantly different, p < 0.01, according
to 2-way ANOVA and Tukey’s protected t tests.
Overstreet et al. Page 12














Alcohol intake in P or SD rats exposed to three cycles of 4.5 or 7% ethanol diets. Data represent
the mean g/kg±S.E.M. ethanol intake. *Significant difference, p < 0.01, from SD rats of the
same condition, t test.
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Prophylactic effects of flumazenil in P or SD rats subjected to three cycles of exposure to 7%
ethanol diet. Rats were exposed continuously to control diet or to three cycles of 5 days’
exposure to 7% ethanol, with 2 days of withdrawal between cycles. Flumazenil (5 mg/kg) or
CMC vehicle were injected i.p. 4 h into the 1st and 2nd withdrawals only. The social interaction
test was conducted 5 h into the 3rd withdrawal. Upper panel: data represent the mean±S.E.M
sec of social interaction for 8–10 rats. Lower panel mean line crosses±S.E.M. Groups with
different letters are significantly different, p < 0.01, according to 2-way ANOVA and Tukey’s
protected t tests.
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The prophylactic effects of SB243,213, 5-HT2C receptor inverse agonist, on anxiety-like
behavior in P and SD rats induced by repeated ethanol withdrawals. Rats were exposed to
control diet (CD) continuously or to three cycles of 5 days’ exposure to 4.5% ethanol, with
two days of withdrawal between cycles. Injections of CMC vehicle (EDV) or 3 mg/kg
SB243,213 (EDSB) were given at 4 h into withdrawal from the 1st and 2nd cycles. The social
interaction test was conducted 5 h into the 3rd withdrawal. Upper panel: data represent the
mean±S.E.M. sec of social interaction for 6 – 8 rats. Lower panel: mean line crosses±S.E.M.
Groups with different letters are significantly different, p < 0.01, according to 2-way ANOVA
and Tukey’s protected t tests.
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Prophylactic effects of CP-154,526, CRF1 receptor antagonist, on anxiety-like behavior of P
Rats exposed to repeated cycles of ethanol exposure. Rats were exposed to control diet (CD)
continuously or three cycles of 5 days’ exposure to 4.5% ethanol diet (EDV or EDCP).
Injections of the vehicle CMC or CP-154,526 (10 mg/kg) were given 4 h into the 1st and 2nd
withdrawals only. The social interaction test was conducted 5 h into the 3rd withdrawal. Upper
panel: data represent the mean±S.E.M. sec of social interaction for 8 – 10 rats. Lower panel:
data represent the mean line crosses±S.E.M. *Significantly different from CD group, p < 0.01,
Tukey’s protected t test. +Significantly different from EDV group, p < 0.01, Tukey’s protected
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t test. Groups: CDP—control diet in P rats; EDPV—ethanol diet in P rats given vehicle; EDPCP
—ethanol diet in P rats given CP-154526.
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Counteraction of restraint stress facilitation of anxiety-like behavior induced by ethanol
withdrawal in P rats by CP-154,526, CRF1 receptor antagonist. Rats were exposed to control
diet (CDP) throughout or to a final period of 5 days of 4.5% ethanol diet (ED). The rats exposed
to ED were either unstressed (EDP) or subjected to 1 h of restraint stress 1 and 6 days prior to
being exposed to ethanol. One group received CMC vehicle (EDPST) 30 prior to restraint and
the other received CP-154,526 (EDPSTCP, 10 mg/kg). Upper panel: data represent the mean
±S.E.M. sec of social interaction for 5–8 rats. Lower panel: data represent the mean line crosses
±S.E.M. *Significantly different from CD group, p < 0.01, Tukey’s protected t test.
+Significantly different from EDV group, p < 0.01, Tukey’s protected t test.
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Table 1
Experimental design for the studies
Experiment Diet features Drug treatments
1 CD vs. 7% ED None
1 cycle vs. 3 cycles
2 CD vs. 4.5% ED None
1 cycle vs. 3 cycles
3 CD vs. 7% ED Flumazenil, benzodiazepine antagonist
3 cycles
4 CD vs.4.5% ED SB-243,213, 5-HT2C inverse agonist
3 cycles
5 CD vs. 4.5% ED CP-154,526, CRF1 receptor antagonist
3 cycles; 2 stresses. 1 cycle
Abbreviations: CD = control diet; ED = ethanol diet; CRF = corticotropin releasing factor.
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